Treatment of vulval vestibulitis with a potent topical steroid [7]

Sexually Transmitted Infections

Volumn 80, Issue 2, 2004, Pages 154-155

  Munday, P E ^a  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; HYDROCORTISONE; PLACEBO; STEROID;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG POTENCY; FEMALE; HUMAN; LETTER; OINTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VULVAR VESTIBULITIS;

EID: 1942521771     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.007328     Document Type: Letter

References (5)

1. McKay M, Frankman O, Horowitz BJ, et al. Vulvar vestibulitis and vestibular papillomatosis. J Reprod Med 1991;36:413-15.
2. Boardman LA, Peipert JF. Vulvar vestibulitis: is it a defined and treatable entity? Clin Obstetr Gynecol 1999;42:945-956.
3. Friedrich EG Jr. Therapeutic studies on vulvar vestibulitis. J Reprod Med 1988;33:514-18.
4. Peckham BM, Maki DG, Patterson JL, et al. Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Am J Obstet Gynecol 1986;154:855-64.
5. Green J, Christmas P, Goldmeier D, et al. A review of physical and psychological factors in vulvar vestibulitis syndrome. Int J STD AIDS 2001;12:705-9.